Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New MRI technique could let doctors watch heart tissue heat up in real time

NCT ID NCT03031587

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new MRI method that measures temperature changes in the heart muscle in real time. The goal is to help doctors see how much tissue is being heated during radiofrequency ablation, a common treatment for irregular heartbeats. 61 people who needed an MRI as part of their care took part. The researchers checked how well the technique worked in real-world conditions, including in patients with arrhythmias.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
MRI thermometric imaging
What this could lead to
If successful, this could enable doctors to see real-time temperature changes in the heart during ablation, potentially making the procedure safer and more effective.
What could go wrong
This is a small, early-stage validation study in 61 people, not a treatment trial. The method may not work well in all patients, such as those with arrhythmias or obesity.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

61 people

The number who actually took part.

Started

May 2017

Finished

Jun 2019

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

15 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient requiring, as part of his/her traditional management of an MRI imaging examination * Adults (age greater than or equal to 18 years) of both sexes * Minors (aged 15 to 18) of both sexes subject to the parental agreement or its legal representative * Patient's oral agreement after reading the information note * Patient affiliate or beneficiary of a social security scheme. Exclusion Criteria: * Patients under 15 years of age * Patient unable to give oral consent * Patients in periods of relative exclusion in relation to another protocol * Patient deprived of liberty by judicial or administrative decision * Major protected by the law * Patient who does not meet the eligibility criteria for an MRI examination with or without injection.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiac mri are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU de Bordeaux

    Pessac, 33604, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.